Alkermes plc.: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value and what the price assumes
Average of FY2023–FY2025 (cash from operations less capital spending), from the statements below.
Starts at revenue growth over the last three years, 9.9% a year (statements).
US Treasury 10-year yield on Nov 13, 2026: 5.15% (US Treasury).
Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.
Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.
Debt less cash at the end of FY2025 (statements); negative means more cash than debt.
What today's price assumes
A market value of $6.7 B means free cash flow growing 4.3% a year for 10 years, then 2.5% for ever, at a 10.15% discount rate.
Revenue grew 9.9% a year over the last three years.
Against the market value, for other rates
Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.
| Discount rate ↓ / growth → | 4.9% | 7.4% | 9.9% | 12.4% | 14.9% |
|---|---|---|---|---|---|
| 8.15% | +41% | +70% | +105% | +148% | +199% |
| 9.15% | +20% | +44% | +72% | +107% | +148% |
| 10.15% | +4% | +24% | +48% | +77% | +111% |
| 11.15% | -7% | +9% | +29% | +54% | +83% |
| 12.15% | -17% | -2% | +15% | +36% | +60% |
On one scale
Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.
Your own DCF model
A full discounted-cash-flow model of Alkermes plc., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Biotechnology
Multiples of its companies with a market value at most 60 days old, times Alkermes plc.'s own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Alkermes plc. | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| P/E | 9.4× / 20.0× / 58.8× | — | net income $242 M | $2.3 B to $14.2 B | 34 |
| Price to sales | 2.2× / 5.0× / 10.2× | 3.8× | revenue $1.5 B | $3.3 B to $15.0 B | 84 |
| Price to book | 3.1× / 4.6× / 12.9× | 3.7× | book equity $1.8 B | $5.6 B to $23.5 B | 69 |
Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.
Against its own history
Alkermes plc.'s multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.
P/E
101.0×Now above its median of 15.2×, in the top quarter of its range; range 12.6× to 109.8× over 24 months.
Price to sales
4.0×Now above its median of 3.5×, in the top quarter of its range; range 2.7× to 5.6× over 30 months.
Price to book
3.7×Now close to its median of 3.6×; range 2.7× to 4.8× over 30 months.
as of Oct 14, 2026. Market caps: the dated values on file since 2020, and in between the SEC's fails-to-deliver closing price times the share count on the latest 10-K or 10-Q cover. Each month divides by the last twelve months' results that had been published by then (a quarter 45 days after it ended, a fiscal year 60 days after), so the past is not read with figures that came out later; months with a loss give no P/E. Newest month: Oct 14, 2026.
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Dec 31, 2025 | $1.5 B | $242 M | $521 M | $40 M | $480 M | $-389 M | SEC annual report (10-K, 20-F) |
| FY2024to Dec 31, 2024 | $1.6 B | $367 M | $439 M | $33 M | $406 M | — | SEC annual report (10-K, 20-F) |
| FY2023to Dec 31, 2023 | $1.7 B | $356 M | $401 M | $48 M | $353 M | $-170 M | SEC annual report (10-K, 20-F) |
| FY2022to Dec 31, 2022 | $1.1 B | $-158 M | $21 M | $38 M | $-17 M | $-2 M | SEC annual report (10-K, 20-F) |
| FY2021to Dec 31, 2021 | $1.2 B | $-48 M | $102 M | $28 M | $74 M | $-45 M | SEC annual report (10-K, 20-F) |
| FY2020to Dec 31, 2020 | $1.0 B | $-111 M | $83 M | $42 M | $41 M | $-1 M | SEC annual report (10-K, 20-F) |
Each figure as filed; the full statements with every line and its filing are on the company page. Market value $6.7 B on Oct 14, 2026.
How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.